National Heart, Lung, and Blood Institute
51 articles with National Heart, Lung, and Blood Institute
-
Obsidio, Inc. Awarded Prestigious Fast Track Small Business Innovation Research Grant by National Heart, Lung, and Blood Institute
7/13/2021
Obsidio, Inc., a privately held company developing minimally invasive embolic products for use in vascular embolotherapy, announced it has been awarded a $2.1 million Fast Track Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute.
-
Baebies Awarded $2.7 Million NIH Grant for Rapid, Near-patient Heparin Monitoring Requiring Low Sample Volume
5/19/2021
Baebies, a growth-stage company developing innovative products to enable early disease detection and multifunctional diagnostics for syndromic testing, was recently awarded $2.7 million in a Phase IIB SBIR grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.
-
T-Cure Bioscience Announces Expansion of Collaboration With the National Institutes of Health for T Cell Receptor (TCR) Therapy Targeting HERV-E for the Treatment of Kidney Cancer
8/4/2020
T-Cure Bioscience, Inc. announced that the Company has extended its ongoing research collaboration with the National Heart Lung and Blood Institute, through a formal Collaborative Research and Development Agreement to advance the Company’s HERV-E targeting TCR therapy for renal cell cancer.
-
National Institutes of Health (NIH) helps fund ColCorona COVID-19 clinical study
5/5/2020
Study examines if colchicine, a common gout medication, can reduce complications associated with COVID-19, slow disease progression, and save patient lives
-
In honor of Black History Month, BioSpace chose to highlight 10 African American leaders in the life sciences, individuals who have prominent roles in the life sciences and biopharmaceutical industry.
-
Numerate Receives $2 Million SBIR Phase II Award to Continue Research Using Its AI-Driven Discovery Platform to Identify New Antiarrhythmic Drug
8/7/2019
Numerate and the UCLA Cardiovascular Research Laboratory to advance collaboration to identify superior therapy for treatment and prevention of ventricular tachycardias and fibrillation
-
The White House budget proposal released earlier this week that slashed spending on the National Institutes of Health and Medicare programs has put members of the administration, including Health and Human Services Secretary Alex Azar on the defensive.
-
The president’s proposed spending plan cuts $4.5 to $5.5 billion from the current budget of the National Institutes of Health, about an 11 percent decrease from 2019.
-
Lovelace Biomedical Wins 5 Year Gene Therapy Contract
1/22/2019
NHLBI has awarded Lovelace Biomedical the Gene Therapy Resource Program contract consecutively since 2007
-
December 14 Research Roundup: Lonesome George’s Genome, Alzheimer’s and Prostate Cancer Tests and...
12/14/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Perceptive Navigation Awarded $3 Million SBIR Grant to Commercialize the Vu-Path™ Ultrasound System
5/29/2018
Perceptive Navigation, LLC announced that it has been awarded a Phase IIB Small Business Innovation Research (SBIR) grant by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).
-
Genetically Engineered Pig Hearts Survive A Record-Breaking Two Years Inside Baboons, National Heart, Lung, and Blood Institute Study
4/6/2016
-
Metactive Awarded Phase I SBIR Grant From The National Heart, Lung, and Blood Institute Of The NIH
7/21/2015
-
Statins Might Not Cause Aching Muscles, But Diabetes Risk Is Real, National Heart, Lung, and Blood Institute Study
3/17/2014
-
CytoSorbents, Inc. Awarded $203K Phase I SBIR Contract From National Heart, Lung, and Blood Institute/National Institutes of Health (NIH) for HemoDefend
9/9/2013
-
Longer Time Being Obese Leads to Heart Disease, National Heart, Lung, and Blood Institute Study
7/17/2013
-
SignaBlok Awarded SBIR Grant from National Heart, Lung, and Blood Institute/National Institutes of Health (NIH) to Develop New Nanotechnology for Diagnostic Imaging of Atherosclerosis
7/10/2012
-
National Heart, Lung, and Blood Institute SMARTT Program Awards AlphaCore Pharma Funding to Manufacture Potential Treatment for Familial Lecithin-Cholesterol Acyltransferase (LCAT) Deficiency
2/14/2012
-
National Heart, Lung, and Blood Institute Release: Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease
12/12/2011
-
RxGen, Inc. and miRagen Therapeutics Announce Award of National Institutes of Health (NIH)-National Heart, Lung, and Blood Institute SBIR Grant to Fund Advanced Preclinical Studies Evaluating the Role of microRNAs in Cardiac Disease
8/25/2011